Dr Reddys Laboratories (RDY) Capital Expenditures (2024 - 2025)

Dr Reddys Laboratories (RDY) recorded quarterly Capital Expenditures of -$59.9 million in Q3 2025, up 25.31% quarter-over-quarter from -$80.2 million in Q2 2025, and up 33.45% on a YoY basis from -$44.9 million in Q3 2024.

Dr Reddys Laboratories (RDY) Capital Expenditures (2024 - 2025) Analysis & Trends

Dr Reddys Laboratories' Capital Expenditures history runs 2 years deep, the most recent figure standing at -$59.9 million for Q3 2025.

  • In Q3 2025, Capital Expenditures rose 33.45% year-over-year to -$59.9 million; the TTM figure through Sep 2025 stood at -$291.3 million (changed N/A YoY), while the FY2026 annual figure was $249.0 million, down 22.67% from the prior year.
  • Capital Expenditures was -$59.9 million for Q3 2025 at Dr Reddys Laboratories, up from -$80.2 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of -$59.9 million in Q3 2025 to a low of -$90.0 million in Q3 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 168.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 110.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 100.80 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 9.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 51.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.09 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 8.83 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.04 Mn
10 Dr Reddys Laboratories 122.03 Mn -51.98 Mn 368.55 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -59.88 Mn
Sep 30, 2025 -59.88 Mn
Jun 30, 2025 -80.17 Mn
Jun 30, 2025 -80.17 Mn
Sep 30, 2024 -89.98 Mn
Sep 30, 2024 -89.98 Mn
Jun 30, 2024 -61.26 Mn
Jun 30, 2024 -61.26 Mn